Partnerships and Opportunities

HealthLinx is actively seeking partners for the following opportunities:

Products

• Ovarian cancer diagnostics OvPlex™ Diagnostic test.
• Co-development partners for the further development of CR014, an anti-vascular leak agent. CR014 has been validated in an in vivo model for acute respiratory disease syndrome (ARDS).
• Exclusive distribution license for its Clear-IT technology for high abundant protein depletion with applications in biomarker discovery and diagnostics.

Vascular Leak/CR014

Non-exclusive license to generate therapeutics against the pathway and targets involved in vascular leak. The US Patent Office recently granted a patent covering compound and target for “Vascular Permeability.”

Cryptomics

• Application of Cryptomics™ platform to human, plant and animal protein sources to generate bioactives as therapeutic lead or functional foods.
• Co-discovery partners with proprietary proteins as unique source material for the Cryptomics™ platform to generate protein-based drug leads.
• Collaborative partners that have access to genomic and proteomic sequences to mine it for “crypteins” or novel protein-based drug leads.
• Partners who have access to proprietary assays that want a novel source of compound libraries (cryptein libraries).